ASXL-Related Disorders Registry

Recruiting

• Conditions: ASXL3 Gene Mutation; Bainbridge-Ropers Syndrome; Bohring-Opitz Syndrome; ASXL2 Gene Mutation; ASXL1 Gene Mutation; Shashi-Pena Syndrome

• Registration Number: NCT03303716
• Lead Sponsor: University of California, Los Angeles

Brief Summary

A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).

Detailed Description

Study participants will be asked to complete a series of brief surveys over time about their medical condition. The researchers will also attain primary medical records.The registry is based at UCLA as the IRB of record with collaborating sites at Boston Children's Hospital, Cincinnati Children's Hospital, and Duke University in a partnership with the Bohring-Opitz Syndrome (BOS) Foundation and ASXL-Rare Research Endowment (ARRE). The BOS Foundation and ARRE are non-profit organizations run by families of patients with ASXL-related disorders that are focused on supporting research. The data is co-managed by the researchers and the family groups. Aggregate data from the Registry will be shared with the participants as well as used for publication. The Registry is HIPPA compliant and follows all the IRB requirements regarding securing and managing patient data.

Study Timeline

• Study Start: 2017-09-20
• Study First Submitted: 2017-10-02
• Study First Submitted QC: 2017-10-05
• Study First Posted: 2017-10-06
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-16
• Last Update Posted: 2024-05-17
• Primary Completion: 2037-09
• Study Completion: 2037-09

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Clinical or molecular diagnosis of an ASXL related disorder

Read More

Exclusion Criteria

• No clinical or molecular diagnosis of an ASXL related disorder

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Natural history, treatment and management strategies of ASXL-related disorders	20 years	Use participant surveys including the GRDR CDE standard questions to collect data on disease history and management. Attain primary medical records with goal of publications to enhance treatment, management and understanding of the natural history of ASXL gene disorders.

Trial Locations

Locations (1)

University of California, Los Angeles; 🇺🇸 Los Angeles, California, United States